Cryptogenic stroke and diabetes: a probable link between silent atrial fibrillation episodes and cerebrovascular disease

References

• American Diabetes Association Standards of Medical Care in Diabetes-2013. Diabetes Care 2013;36:S11-66
   PubMed Web of Science ®Google Scholar
• Guariguata L. By the numbers: new estimates from the IDF Diabetes Atlas Update for 2012. Diabetes Res Clin Pract 2012;98:524-5
   PubMed Web of Science ®Google Scholar
• Olefsky JM. Prospects for research in diabetes mellitus. JAMA 2001;285(5):628-32
   PubMed Web of Science ®Google Scholar
• Bethel MA, Sloan FA, Belsky D, Feinglos MN. Longitudinal incidence and prevalence of adverse outcomes of diabetes mellitus in elderly patients. Arch Intern Med 2007;167(9):921-7
   PubMedGoogle Scholar
• Geiss LS, Herman WH, Smith PJ. Mortality in non-insulin-dependent diabetes (Chapter 11). 2nd edition. Diabetes in America; 1995
   Google Scholar
• Emerging Risk Factors Collaboration. Sarwar N, Gao P, Seshasai SR, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010;375(9733):2215-22
   PubMed Web of Science ®Google Scholar
• Kamalesh M, Shen J, Eckert GJ. Long term postischemic stroke mortality in diabetes: a veteran cohort analysis. Stroke 2008;39(10):2727-31
   PubMed Web of Science ®Google Scholar
• Nwaneri C, Cooper H, Bowen-Jones D. Mortality in type 2 diabetes mellitus. magnitude of the evidence from a systematic review and meta-analysis. Br J Diab Vasc Dis 2013;13(4):192-207
   Google Scholar
• Garcia JT, Robles LR. Epidemiology of stroke in patients with diabetes. Av Diabetol 2010;26:397-402
   Google Scholar
• Luitse MJ, Biessels GJ, Rutten GE, Kappelle LJ. Diabetes, hyperglycaemia, and acute ischaemic stroke. Lancet Neurol 2012;11(3):261-71
   PubMed Web of Science ®Google Scholar
• Jorfida M, Cerrato P. Ictus criptogenetico: la fibrillazione atriale alla sbarra degli imputati. Emergency care journal. Anno V Numero III. Giugno 2009;32-40
   Google Scholar
• Nichols GA, Reinier K, Chugh SS. Independent contribution of diabetes to increased prevalence and incidence of atrial fibrillation. Diabetes Care 2009;32(10):1851-6
   PubMed Web of Science ®Google Scholar
• Healey JS, Connolly SJ, Gold MR, ASSERT Investigators. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 2012;366(2):120-9
   PubMed Web of Science ®Google Scholar
• Pop-Busui R. What do we know and we do not know about cardiovascular autonomic neuropathy in diabetes. J Cardiovasc Transl Res 2012;5(4):463-78
   PubMed Web of Science ®Google Scholar
• DCCT. The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT). Diabetologia 1998;41:416-23
   PubMed Web of Science ®Google Scholar
• Pop-Busui R. Cardiac autonomic neuropathy in diabetes: a clinical perspective. Diabetes Care 2010;33:434-41
   PubMed Web of Science ®Google Scholar
• Pop-Busui R, Low PA, Waberski BH, et al. Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC). Circulation 2009;119:2886-93
   PubMed Web of Science ®Google Scholar
• Spallone V, Ziegler D, Freeman R, et al. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diab Metab Res Rev 2012; In press
   Web of Science ®Google Scholar
• Kempler P, Tesfaye S, Chaturvedi N, et al. Autonomic neuropathy is associated with increased cardiovascular risk factors: the EURODIAB IDDM Complications Study. Diabet Med 2002;19:900-9
   PubMed Web of Science ®Google Scholar
• Low PA, Benrud-Larson LM, Sletten DM, et al. Autonomic symptoms and diabetic neuropathy: a population-based study. Diabetes Care 2004;27:2942-7
   PubMed Web of Science ®Google Scholar
• Kennedy WR, Navarro X, Sutherland DE. Neuropathy profile of diabetic patients in a pancreas transplantation program. Neurology 1995;45:773-80
   PubMed Web of Science ®Google Scholar
• Singh JP, Larson MG, O'Donnell CJ, et al. Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study). Am J Cardiol 2000;86:309-12
   PubMed Web of Science ®Google Scholar
• Wu JS, Yang YC, Lin TS, et al. Epidemiological evidence of altered cardiac autonomic function in subjects with impaired glucose tolerance but not isolated Impaired fasting glucose. J Clin Endocrinol Metab 2007;92:3885-9
   PubMed Web of Science ®Google Scholar
• Pop-Busui R. Cardiac autonomic neuropathy in diabetes: a clinical perspective. Diabetes Care 2010;33(2):434-41
   PubMed Web of Science ®Google Scholar
• Marfella R, Sasso FC, Siniscalchi M, et al. Brief episodes of silent atrial fibrillation predict clinical vascular brain disease in type 2 diabetic patients. Am Coll Cardiol 2013;62(6):525-30
   PubMed Web of Science ®Google Scholar
• Kirchhof P, Bax J, Blomstrom-Lundquist C, et al. Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference “research perspectives in AF”. Eur Heart J 2009;30:2969-77
   PubMed Web of Science ®Google Scholar
• Nattel S. New ideas about atrial fibrillation 50 years on. Nature 2002;415:219-26
   PubMed Web of Science ®Google Scholar
• Wakili R, Voigt N, Kaab S, et al. Recent advances in the molecular pathophysiology of atrial fibrillation. J Clin Invest 2011;121:2955-68
   PubMed Web of Science ®Google Scholar
• Allessie MA, Boyden PA, Camm AJ, et al. Pathophysiology and prevention of atrial fibrillation. Circulation 2001;103:769-77
   PubMed Web of Science ®Google Scholar
• Schotten U, Verheule S, Kirchhof P, et al. Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Physiol Rev 2011;91:265-325
   PubMed Web of Science ®Google Scholar
• Iwasaki YK, Nishida K, Kato T, et al. Atrial fibrillation pathophysiology: implications for management. Circulation 2011;124:2264-74
   PubMed Web of Science ®Google Scholar
• Arora R. Recent insights into the role of the autonomic nervous system in the creation of substrate for atrial fibrillation: implications for therapies targeting the atrial autonomic nervous system. Circ Arrhythm Electrophysiol 2012;5:850-9
   PubMed Web of Science ®Google Scholar
• Kapa S, Venkatachalam KL, Asirvatham SJ. The autonomic nervous system in cardiac electrophysiology: an elegant interaction and emerging concepts. Cardiol Rev 2010;18:275-84
   PubMed Web of Science ®Google Scholar
• Randall WC, Szentivanyi M, Pace JB, et al. Patterns of sympathetic nerve projections onto the canine heart. Circ Res 1968;22:315-23
   PubMed Web of Science ®Google Scholar
• Hou Y, Scherlag BJ, Lin J, et al. Ganglionated plexi modulate extrinsic cardiac autonomic nerve input: effects on sinus rate, atrioventricular conduction, refractoriness, and inducibility of atrial fibrillation. J Am Coll Cardiol 2007;50:61
   PubMed Web of Science ®Google Scholar
• Ng J, Villuendas R, Cokic I, et al. Autonomic remodeling in the left atrium and pulmonary veins in heart failure: creation of a dynamic substrate for atrial fibrillation. Circ Arrhythm Electrophysiol 2011;4:388-96
   PubMed Web of Science ®Google Scholar
• Jayachandran JV, Sih HJ, Winkle W, et al. Atrial fibrillation produced by prolonged rapid atrial pacing is associated with heterogeneous changes in atrial sympathetic innervation. Circulation 2000;101:1185-91
   PubMed Web of Science ®Google Scholar
• Gould PA, Yii M, McLean C, et al. Evidence for increased atrial sympathetic innervations in persistent human atrial fibrillation. Pacing Clin Electrophysiol 2006;29:821-9
   PubMed Web of Science ®Google Scholar
• Tan AY, Zhou S, Ogawa M, et al. Neural mechanisms of paroxysmal atrial fibrillation and paroxysmal atrial tachycardia in ambulatory canines. Circulation 2008;118:916-25
   Web of Science ®Google Scholar
• Piccirillo G, Ogawa M, Song J, et al. Power spectral analysis of heart rate variability and autonomic nervous system activity measured directly in healthy dogs and dogs with tachycardia-induced heart failure. Heart Rhythm 2009;6:546-52
   PubMed Web of Science ®Google Scholar
• Bettoni M, Zimmermann M. Autonomic tone variations before the onset of paroxysmal atrial fibrillation. Circulation 2002;105:2753-9
   PubMed Web of Science ®Google Scholar
• Fioranelli M, Piccoli M, Mileto GM, et al. Analysis of heart rate variability five minutes before the onset of paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 1999;22:743-9
   PubMed Web of Science ®Google Scholar
• Hnatkova K, Waktare JEP, Sopher SM, et al. A relationship between fluctuations in heart rate and the duration of subsequent episodes of atrial fibrillation. Pacing Clin Electrophysiol 1998;21:181-5
   PubMed Web of Science ®Google Scholar
• Zimmermann M, Kalusche D. Fluctuation in autonomic tone is a major determinant of sustained atrial arrhythmias in patients with focal ectopy originating from the pulmonary veins. J Cardiovasc Electrophysiol 2001;12:285-91
   PubMed Web of Science ®Google Scholar
• Dimmer C, Tavernier R, Gjorgov N, et al. Variations of autonomic tone preceding onset of atrial fibrillation after coronary artery bypass grafting. Am J Cardiol 1998;82:22-5
   PubMed Web of Science ®Google Scholar
• Wen ZC, Chen SA, Tai CT, et al. Role of autonomic tone in facilitating spontaneous onset of typical atrial flutter. J Am Coll Cardiol 1998;31:602-7
   PubMed Web of Science ®Google Scholar
• Coccagna G, Capucci A, Bauleo S, et al. Paroxysmal atrial fibrillation in sleep. Sleep 1997;20:396-8
   PubMed Web of Science ®Google Scholar
• Klingenheben T, Grönefeld G, Li YG, et al. Heart rate variability to assess changes in cardiac vagal modulation before the onset of paroxysmal atrial fibrillation in patients with and without structural heart disease. Ann Noninvas Electrocardiol 1999;4:19-26
   Google Scholar
• Herweg B, Dalal P, Nagy B, et al. Power spectral analysis of heart period variability of preceding sinus rhythm before initiation of paroxysmal atrial fibrillation. Am J Cardiol 1998;82:869-74
   PubMed Web of Science ®Google Scholar
• Bettoni M, Zimmermann M. Autonomic tone variations before the onset of paroxysmal atrial fibrillation. Circulation 2002;105:2753-9
   PubMed Web of Science ®Google Scholar
• Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation 1996;93:1043-65
   PubMed Web of Science ®Google Scholar
• Negishi K, Seicean S, Negishi T, et al. Relation of heart-rate recovery to new onset heart failure and atrial fibrillation in patients with diabetes mellitus and preserved ejection fraction. Am J Cardiol 2013;111(5):748-53
   Google Scholar
• Arboix A, Garcı´a-Eroles L, Massons JB, et al. Atrial fibrillation and stroke: clinical presentation of cardioembolic versus atherothrombotic infarction. Int J Cardiol 2000;73:33-42
   PubMed Web of Science ®Google Scholar
• Biblo LA, Yuan Z, Quan KJ, et al. Risk of stroke in patients with atrial flutter. Am J Cardiol 2001;87:346-9
   PubMed Web of Science ®Google Scholar
• Karatas M, Dilek A, Erkan H, et al. Functional outcome in stroke patients with atrial fibrillation. Arch Phys Med Rehabil 2000;81:1025-9
   PubMed Web of Science ®Google Scholar
• Lin HJ, Wolf PA, Benjamin EJ, et al. Newly diagnosed atrial fibrillation and acute stroke. The Framingham study. Stroke 1995;26:1527-30
   PubMed Web of Science ®Google Scholar
• Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke 1991;22:983-8
   PubMed Web of Science ®Google Scholar
• Marini C, De Santis F, Sacco S, et al. Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study. Stroke 2005;36(6):1115-19
   PubMed Web of Science ®Google Scholar
• Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449-57
   PubMed Web of Science ®Google Scholar
• The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990;323:1505-11
   PubMed Web of Science ®Google Scholar
• Hart RG, Halperin JL, Pearce LA, Stroke Prevention in Atrial Fibrillation Investigators. Lessons from the stroke prevention in atrial fibrillation trials. Ann Intern Med 2003;138:831-8
   PubMed Web of Science ®Google Scholar
• Hart RG, Pearce LA, Koudstaal PJ. Transient ischemic attacks in patients with atrial fibrillation: implications for secondary prevention: the European Atrial Fibrillation Trial and Stroke Prevention in Atrial Fibrillation III Trial. Stroke 2004;35:948-51
   PubMed Web of Science ®Google Scholar
• Hylek EM, Go AS, Chang Y, et al. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med 2003;349:1019-26
   PubMed Web of Science ®Google Scholar
• O'Donnell M, Oczkowski W, Fang J, et al. Influence of pre-admission antithrombotic therapy on stroke severity in patients with atrial fibrillation: an observational study. Lancet Neurol 2006;5:749-54
   PubMed Web of Science ®Google Scholar
• Kimura K, Minematsu K, Yamaguchi T. Atrial fibrillation as a predictive factor for severe stroke and early death in 15,831 patients with acute ischaemic stroke. J Neurol Neurosurg Psychiatry 2005;76:679-83
   PubMed Web of Science ®Google Scholar
• Paciaroni M, Agnelli G, Caso V, et al. Atrial fibrillation in patients with first-ever stroke: frequency, antithrombotic treatment before the event and effect on clinical outcome. J Thromb Haemost 2005;3:1218-23
   PubMed Web of Science ®Google Scholar
• Sandercock P, Bamford J, Dennis M, et al. Atrial fibrillation and stroke: prevalence in different types of stroke and influence on early and long term prognosis (Oxfordshire Community Stroke Project). BMJ 1992;305:1460-5
   PubMed Web of Science ®Google Scholar
• Bell C, Kapral M. Use of ambulatory electrocardiography for the detection of paroxysmal atrial fibrillation in patients with stroke. Canadian Task Force on Preventive Health Care. Can J Neurol Sci 2000;27:25-31
   PubMed Web of Science ®Google Scholar
• Nomura K, Hamamoto Y, Takahara S, et al. Relationship between carotid intima-media thickness and silent cerebral infarction in Japanese subjects with type 2 diabetes. Diabetes Care 2010;33:168-70
   PubMed Web of Science ®Google Scholar
• Kempster PA, Gerraty RP, Gates PC. Asymptomatic cerebral infarction in patients with chronic atrial fibrillation. Stroke 1988;19:955-7
   PubMed Web of Science ®Google Scholar
• Bernick C, Kuller L, Dulberg C, et al. Cardiovascular Health Study Collaborative Reseach Group. Silent MRI infarcts and the risk of future stroke: the Cardiovascular Health Study. Neurology 2001;57:1222-9
   PubMed Web of Science ®Google Scholar
• Vermeer SE, Hollander M, van Dijk EJ, et al. Silent brain infarcts and white-matter lesions increase stroke risk in the general population: the Rotterdam Scan study. Stroke 2003;34:1126-9
   PubMed Web of Science ®Google Scholar
• Kario K, Shimada K, Matsuo T, et al. Silent and clinically overt stroke in older Japanese subjects with white-coat and sustained hypertension. J Am Coll Cardiol 2001;38:238-45
   PubMed Web of Science ®Google Scholar
• Kobayashi S, Okada K, Koide H, et al. Subcortical silent brain infarction as a risk factor for clinical stroke. Stroke 1997;28:1932-9
   PubMed Web of Science ®Google Scholar
• Camm AJ, Corbucci G, Padeletti L. Usefulness of continuous electrocardiographic monitoring for atrial fibrillation. Am J Cardiol 2012;110:270-6
   PubMed Web of Science ®Google Scholar
• The Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-33
   PubMed Web of Science ®Google Scholar
• Van Gelder IC, Hagens VE, Bosker HA, et al. Comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002;347:1834-40
   PubMed Web of Science ®Google Scholar
• Ionescu-Ittu R, Abrahamowicz M, Jackevicius CA, et al. Comparative effectiveness of rhythm control vs rate control drug treatment effect on mortality in patients with atrial fibrillation. Arch Intern Med 2012;172:997-1004
   PubMedGoogle Scholar
• Tsadok MA, Jackevicius CA, Essebag V, et al. Rhythm versus rate control therapy and subsequent stroke or transient ischemic attack in patients with atrial fibrillation. Circulation 2012;126:2680-7
   PubMed Web of Science ®Google Scholar
• Botto GL, Padeletti L, Santini M, et al. Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events. J Cardiovasc Electrophysiol 2009;20:241-8
   PubMed Web of Science ®Google Scholar
• Engdahl J, Andersson L, Mirskaya M, Rosenqvist M. Stepwise screening of atrial fibrillation in a 75-year old population. Circulation 2013;127:930-7
   PubMed Web of Science ®Google Scholar
• Medi C, Evered L, Silbert B, et al. Subtle post-procedural cognitive dysfunction after atrial fibrillation ablation. J Am Coll Cardiol 2013;62:531-9
   PubMed Web of Science ®Google Scholar
• Bunch TJ, Crandall BG, Weiss P, et al. Patients treated with catheter ablation for atrial fibrillation have long-term rates of death, stroke, and dementia similar to patients without atrial fibrillation. J Cardiovasc Electrophysiol 2011;22:839-45
   PubMed Web of Science ®Google Scholar
• Putaala J, Liebkind R, Gordin D, et al. Diabetes mellitus and ischemic stroke in the young: clinical features and long-term prognosis. Neurology 2011;76:1831-7
   PubMed Web of Science ®Google Scholar